Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 3
1991 3
1992 1
1993 1
1994 4
1995 2
1996 3
1997 2
1998 2
1999 4
2000 7
2001 2
2002 6
2003 7
2004 4
2005 4
2006 1
2007 1
2008 5
2009 4
2010 3
2011 2
2012 3
2013 6
2014 4
2015 7
2016 8
2017 4
2018 2
2019 5
2020 19
2021 12
2022 7
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
Damania B, Dittmer DP. Damania B, et al. J Med Virol. 2023 May;95(5):e28773. doi: 10.1002/jmv.28773. J Med Virol. 2023. PMID: 37212317 Free PMC article. Review.
This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that manifests under diverse and divergent circumstances. We begin with a historical introduction of KS and KS-associated herpesvirus (KSHV), highlight the diversity of clinical presen …
This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that manifests under diverse and divergent c …
Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.
Zhang C, Wu Z, Li JW, Tan K, Yang W, Zhao H, Wang GQ. Zhang C, et al. J Med Virol. 2021 Mar;93(3):1378-1386. doi: 10.1002/jmv.26634. Epub 2020 Nov 1. J Med Virol. 2021. PMID: 33107641 Review.
Since December 2019, coronavirus disease (COVID-19) has rapidly swept the world. So far, more than 30 million people have been infected and nearly one million have died. Although the world is still in the stage of COVID-19 pandemic, the treatment of new cases …
Since December 2019, coronavirus disease (COVID-19) has rapidly swept the world. So far, more than 30 million people have been …
Current meta-analysis does not support the possibility of COVID-19 reinfections.
Arafkas M, Khosrawipour T, Kocbach P, Zielinski K, Schubert J, Mikolajczyk A, Celinska M, Khosrawipour V. Arafkas M, et al. J Med Virol. 2021 Mar;93(3):1599-1604. doi: 10.1002/jmv.26496. Epub 2020 Sep 27. J Med Virol. 2021. PMID: 32897549
Coronavirus disease 2019 (COVID-19) reinfections could be a major aggravating factor in this current pandemic, as this would further complicate potential vaccine development and help to maintain worldwide virus pockets. ...Available patient data in these reports was …
Coronavirus disease 2019 (COVID-19) reinfections could be a major aggravating factor in this current pandemic, as this would further …
Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.
Li T, Cui Z, Jia Y, Liang Z, Nie J, Zhang L, Wang M, Li Q, Wu J, Xu N, Liu S, Li X, An Y, Han P, Zhang M, Li Y, Qu X, Wang Q, Huang W, Wang Y. Li T, et al. J Med Virol. 2022 May;94(5):2108-2125. doi: 10.1002/jmv.27596. Epub 2022 Jan 28. J Med Virol. 2022. PMID: 35032057 Free PMC article.
Variants of SARS-CoV-2 continue to emerge, posing great challenges in outbreak prevention and control. It is important to understand in advance the impact of possible variants of concern (VOCs) on infectivity and antigenicity. ...
Variants of SARS-CoV-2 continue to emerge, posing great challenges in outbreak prevention and control. It is important to understand …
SARS-CoV-2 evolves to reduce but not abolish neutralizing action.
Zhang Y, Ndzouboukou JB, Lin X, Hou H, Wang F, Yuan L, Gan M, Yao Z, Fu H, Cao J, Fan X. Zhang Y, et al. J Med Virol. 2023 Jan;95(1):e28207. doi: 10.1002/jmv.28207. Epub 2022 Oct 19. J Med Virol. 2023. PMID: 36217880 Free PMC article.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) have prolonged coronavirus disease 2019 (COVID-19) pandemic by escaping pre-existing immunity acquired by natural infection or vaccination. ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) have prolonged coronavirus disease 2019 (COVI …
141 results